SARS-CoV-2 nsp12 Recombinant eiwit (N-GST & C-His)

2'-O-methyltransferase nsp16, 3C-like proteinase nsp5, 3CL-PRO, 3CLp, EC:2.1.1.56, EC:2.1.1.57, EC:2.7.7.48, EC:2.7.7.50, EC:3.1.13.-, EC:3.4.19.12, EC:3.4.22.-, EC:3.4.22.69, EC:3.6.4.12, EC:3.6.4.13, EC:4.6.1.-, ExoN, GFL, Growth factor-like peptide, Guanine-N7 methyltransferase nsp14, Hel, Helicase nsp13, Host translation inhibitor nsp1, Leader protein, Main protease, Mpro, NendoU, Non-structural protein 1, Non-structural protein 10, Non-structural protein 12, Non-structural protein 13, Non-structural protein 14, Non-structural protein 15, Non-structural protein 16, Non-structural protein 2, Non-structural protein 3, Non-structural protein 4, Non-structural protein 5, Non-structural protein 6, Non-structural protein 7, Non-structural protein 8, Non-structural protein 9, ORF1ab polyprotein, PL-PRO, PL2-PRO, Papain-like protease nsp3, Papain-like proteinase, Pol, Proofreading exoribonuclease nsp14, RNA-capping enzyme subunit nsp9, RNA-directed RNA polymerase nsp12, RdRp, Replicase polyprotein 1ab, SARS coronavirus main proteinase, Uridylate-specific endoribonuclease nsp15, Viral protein genome-linked nsp9, nsp1, nsp10, nsp12, nsp13, nsp14, nsp15, nsp16, nsp2, nsp3, nsp4, nsp5, nsp6, nsp7, nsp8, nsp9, p65 homolog, pp1ab, rep

P0DTD1

E. coli

Recombinant

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

>90% as determined by SDS-PAGE.

Lyophilized

Lyophilized from a solution in PBS pH 7.4, 1 mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

For research use only

Ser4393-Gln5324

Severe acute respiratory syndrome coronavirus 2